Genealogical studies in LRRK2-associated Parkinson's disease in central Norway

Parkinsonism and Related Disorders

Volumn 16, Issue 8, 2010, Pages 527-530

  Johansen, Krisztina K ^a,b   Hasselberg, Kåre ^a   White, Linda R ^a,b   Farrer, Matthew J ^c   Aasly, Jan O ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c MAYO CLINIC   (United States)

Author keywords

Common founder; Family studies; Haplotype analysis; P.G2019S

Indexed keywords

GLYCINE; LEUCINE RICH REPEAT KINASE 2; SERINE;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 12Q; CONSANGUINEOUS MARRIAGE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENEALOGY; GENETIC ASSOCIATION; GENETIC MARKER; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PARKINSON DISEASE; PEDIGREE; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; FOUNDER EFFECT; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION; NORWAY; PARKINSON DISEASE; PEDIGREE; PENETRANCE; PROTEIN-SERINE-THREONINE KINASES;

EID: 77956175000     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.05.005     Document Type: Article

References (26)

1. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005, 365:412-415.
2. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005, 365:415-416.
3. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005, 365:410-412.
4. Healy D.G., Falchi M., O'Sullivan S.S., Bonifati V., Durr A., Bressman S., et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008, 7:583-590.
5. Aasly J.O., Toft M., Fernandez-Mata I., Kachergus J., Hulihan M., White L.R., et al. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 2005, 57:762-765.
6. Goldwurm S., Zini M., Di Fonzo A., De Gaspari D., Siri C., Simons E.J., et al. LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism Relat Disord 2006, 12:410-419.
7. Ross O.A., Toft M., Whittle A.J., Johnson J.L., Papapetropoulos S., Mash D.C., et al. Lrrk2 and Lewy body disease. Ann Neurol 2006, 59:388-393.
8. Giasson B.I., Covy J.P., Bonini N.M., Hurtig H.I., Farrer M.J., Trojanowski J.Q., et al. Biochemical and pathological characterization of Lrrk2. Ann Neurol 2006, 59:315-322.
9. Rajput A., Dickson D.W., Robinson C.A., Ross O.A., Dachsel J.C., Lincoln S.J., et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 2006, 67:1506-1508.
10. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., et al. LRRK2 G2019S as a cause of Parkinson's disease in north African Arabs. N Engl J Med 2006, 354:422-423.
11. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006, 354:424-425.
12. Tan E.K., Shen H., Tan L.C., Farrer M., Yew K., Chua E., et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 2005, 384:327-329.
13. Funalot B., Nichols W.C., Perez-Tur J., Mercier G., Lucotte G. Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease. Genet Test 2006, 10:290-293.
14. Gaig C., Ezquerra M., Marti M.J., Munoz E., Valldeoriola F., Tolosa E. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 2006, 63:377-382.
15. Lesage S., Janin S., Lohmann E., Leutenegger A.L., Leclere L., Viallet F., et al. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans. Arch Neurol 2007, 64:425-430.
16. Marongiu R., Ghezzi D., Ialongo T., Soleti F., Elia A., Cavone S., et al. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. Mov Disord 2006, 21:1232-1235.
17. Papapetropoulos S., Adi N., Shehadeh L., Bishopric N., Singer C., Argyriou A.A., et al. Is the G2019S LRRK2 mutation common in all southern European populations?. J Clin Neurosci 2008, 15:1027-1030.
18. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005, 76:672-680.
19. Zabetian C.P., Hutter C.M., Yearout D., Lopez A.N., Factor S.A., Griffith A., et al. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 2006, 79:752-758.
20. Zabetian C.P., Morino H., Ujike H., Yamamoto M., Oda M., Maruyama H., et al. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Neurology 2006, 67:697-699.
21. Lesage S., Leutenegger A.L., Ibanez P., Janin S., Lohmann E., Durr A., et al. LRRK2 haplotype analyses in European and north African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 2005, 77:330-332.
22. Warren L., Gibson R., Ishihara L., Elango R., Xue Z., Akkari A., et al. A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Parkinsonism Relat Disord 2008, 14:77-80.
23. Benamer H.T. The ancestry of LRRK2 Gly2019Ser parkinsonism. Lancet Neurol 2008, 7:769-770. author reply 770-771.
24. Bar-Shira A., Hutter C.M., Giladi N., Zabetian C.P., Orr-Urtreger A. Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries. Neurogenetics 2009, 10:355-358.
25. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
26. Berglund B. Alstahaug på Helgeland 1000-1750 2007, Tapir Academic Press, Trondheim.